Literature DB >> 33765184

[Short-term radiotherapy with 5 × 5 Gy followed by preoperative chemotherapy and resection in patients with locally advanced rectal carcinoma results in improved disease-free survival].

Simon Kirste1, Emmanouil Fokas2, Claus Rödel2.   

Abstract

Entities:  

Year:  2021        PMID: 33765184     DOI: 10.1007/s00066-021-01763-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

2.  Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes.

Authors:  Fausto Petrelli; Francesca Trevisan; Mary Cabiddu; Giovanni Sgroi; Lorenza Bruschieri; Emanuele Rausa; Michele Ghidini; Luca Turati
Journal:  Ann Surg       Date:  2020-03       Impact factor: 12.969

3.  Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.

Authors:  Emmanouil Fokas; Michael Allgäuer; Bülent Polat; Gunther Klautke; Gerhard G Grabenbauer; Rainer Fietkau; Thomas Kuhnt; Ludger Staib; Thomas Brunner; Anca-Ligia Grosu; Wolff Schmiegel; Lutz Jacobasch; Jürgen Weitz; Gunnar Folprecht; Anke Schlenska-Lange; Michael Flentje; Christoph-Thomas Germer; Robert Grützmann; Matthias Schwarzbach; Vittorio Paolucci; Wolf O Bechstein; Tim Friede; Michael Ghadimi; Ralf-Dieter Hofheinz; Claus Rödel
Journal:  J Clin Oncol       Date:  2019-05-31       Impact factor: 44.544

4.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

5.  Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial.

Authors:  Maxime J M van der Valk; Corrie A M Marijnen; Boudewijn van Etten; Esmée A Dijkstra; Denise E Hilling; Elma Meershoek-Klein Kranenbarg; Hein Putter; Annet G H Roodvoets; Renu R Bahadoer; Tone Fokstuen; Albert Jan Ten Tije; Jaume Capdevila; Mathijs P Hendriks; Ibrahim Edhemovic; Andrès M R Cervantes; Derk Jan A de Groot; Per J Nilsson; Bengt Glimelius; Cornelis J H van de Velde; Geke A P Hospers
Journal:  Radiother Oncol       Date:  2020-03-30       Impact factor: 6.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.